logo
Medicaid Cuts Set to Drain Revenue at Elite Teaching Hospitals

Medicaid Cuts Set to Drain Revenue at Elite Teaching Hospitals

Mint3 days ago
(Bloomberg) -- Few in the US healthcare sector are immune to the effects of Washington's recent cuts to Medicaid, even the cash-rich teaching hospitals affiliated with top-notch medical schools.
These facilities, often known as academic medical centers or AMCs, are usually seen as the cream of the industry crop for their top-tier credit ratings and ability to churn out revenue. But federal cuts to the public health insurance program for low-income and disabled people will lead to less funding for teaching hospitals around the country. In response, they've already started to reduce staff and scale back operations.
In June, Vanderbilt University Medical Center said it would lay off as much as 650 people. About 300 positions are being eliminated at the health system tied to the University of Pennsylvania, an Ivy League school. And just last week, the University of Vermont Health Network announced staff and spending cuts.
Add in other industry challenges such as rising costs and labor shortages — which stretch back to the Covid-19 pandemic — and AMCs, once seen as a trophy, now look like a liability.
'It could be material potentially for individual credits,' said Brad Spielman, a vice president at Moody's Ratings, referring to Medicaid funding, which was cut by nearly $1 trillion over ten years. 'Money withdrawn is money withdrawn.'
The risk to AMCs is a drop in revenue as some patients lose Medicaid coverage and reimbursements for their care decline. That could spell trouble for schools with teaching hospitals. Medical facilities contributed to 45% of their total revenue in fiscal 2023, according to a Moody's report.
For universities, that income from their medical centers can be 'very good in the good times and not so great in the bad times,' said Patrick Ronk, an analyst covering higher education at Moody's.
In recent years, some AMCs have increased their exposure to Medicaid patients by acquiring community hospitals in deals meant to expand their networks and boost income. Members of the Association of American Medical Colleges — which includes AMCs, medical schools and academic societies — make up just 5% of the nation's hospitals but provide about 27% of Medicaid hospitalizations.
AMCs won't just be affected by Medicaid cuts, which will be phased in over the next few years. The Trump Administration has also frozen billions in research grants and moved to scale back other federal support, which will also put a strain on operations, according to Leonard Marquez, who oversees government relations and advocacy at the Association of American Medical Colleges.
It adds up to 'death by a thousand cuts,' Marquez said. 'I've never seen a situation where we have so many different lines of attack coming at us.'
More stories like this are available on bloomberg.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mizoram: 39 people tested positive for COVID-19 so far in 2025
Mizoram: 39 people tested positive for COVID-19 so far in 2025

News18

time35 minutes ago

  • News18

Mizoram: 39 people tested positive for COVID-19 so far in 2025

Agency: Aizawl, Aug 10 (PTI) Thirty-nine people have tested positive for COVID-19 in Mizoram so far this year, officials said on Sunday. Of them, 28 people have recovered from the infection. According to the Integrated Disease Surveillance Programme (IDSP), 11 people are currently undergoing treatment for COVID-19. All of them are from the Aizawl district Twenty-seven suspected patients were tested on August 8, and one of them was found positive for the infection. On August 5, 10 people tested positive for COVID-19. They are out of danger, officials said. PTI CORR SOM First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Indian-origin Dr Vinay Prasad returns to FDA weeks after exit; Laura Loomer calls it 'egregious decision'
Indian-origin Dr Vinay Prasad returns to FDA weeks after exit; Laura Loomer calls it 'egregious decision'

Time of India

time3 hours ago

  • Time of India

Indian-origin Dr Vinay Prasad returns to FDA weeks after exit; Laura Loomer calls it 'egregious decision'

Dr Vinay Prasad is back at his FDA job weeks after exit that was prompted by right-wing activist Laura Loomer's campaigning against Prasad. Dr Vinay Prasad, the Indian-origin vaccine chief of the FDA who was forced to resign in July after far-right activist Laura Loomer led a campaign against him, has been reinstated to his job in an unusual instance. Laura Loomer pointed out the critical comments that Dr Prasad made about President Donald Trump before joining the administration, while some of his decisions to deny drug approvals also came under fire. A Department of Health and Human Services spokesperson confirmed to the New York Times that Dr Prasad is returning to the agency. 'At the F.D.A.'s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' Andrew Nixon, a health department spokesman, said in a statement. The NYT report observed that Dr Prasad's rehiring suggests that the health secretary, Robert F Kennedy Jr., and the FDA commissioner, Dr Marty Makary, remain influential enough in the Trump administration to employ someone who had previously expressed disdain for Trump and his followers. Loomer reacted to the reinstatement and called in another "egregious personnel decision". "In another egregious personnel decision under the Trump administration, it is now being reported that longtime progressive Marxist Vinay Prasad who referred to President Trump's supporters as criminals and compared them to drug addicts after saying he stabbed a Trump voodoo doll to 'curse Trump' is apparently back at FDA," Loomer wrote. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Everyone is suddenly using this AI language learning app Talkpal AI Learn More Undo RFK Jr tapped Dr Prasad in May when the previous head of the FDA's Center for Biologics Evaluation left the role. During the Covid-19 pandemic, Dr Prasad gained prominence as an outspoken critic of vaccines and mask mandate. In his short stint at the FDA since May, Dr Prasad limited the use of Covid-19 vaccines and promoted warnings about a rare side effect of the vaccines. When he resigned from his role weeks ago, a department spokesperson told the NYT: "Dr. Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family." Kennedy, however, opposed Prasad's departure from the role and remained invested in bringing him back. Dr Prasad was born and brought up in Ohio and Chicago to Indian immigrant parents.

China's War On Mosquitoes To Eradicate Chikungunya Revives Covid Lockdown Memories: Report
China's War On Mosquitoes To Eradicate Chikungunya Revives Covid Lockdown Memories: Report

News18

time4 hours ago

  • News18

China's War On Mosquitoes To Eradicate Chikungunya Revives Covid Lockdown Memories: Report

Chinese authorities have mobilised their entire health apparatus in a "war on mosquitoes" to eradicate a Chikungunya outbreak in Guangdong province. Authorities in China have launched what is believed to be a 'war on mosquitoes" to eradicate a growing outbreak of the Chikungunya virus in Guangdong province. The country's health apparatus has mobilised in a way not seen since the mass lockdowns during the Covid-19 pandemic. The campaign involves drones and even other predatory creatures to eliminate mosquitoes and fumigators are searching every village, reflecting the seriousness of the Chinese government in this endeavour. Officials in Guangdong have reported more than 7,000 cases of the virus since last month, according to the Financial Times. The outbreak is primarily concentrated in Foshan, a major manufacturing city home to approximately 9 million people, but officials have located cases in Hong Kong, Macau and the neighbouring Hunan province. While Chikungunya is rarely fatal and authorities have not reported any deaths from the ongoing outbreak, the Chinese government has sprung into action to contain the disease by conducting regular fumigation and entering homes to check for stagnant water in which mosquitoes can breed. Officials in the Guangdong province are even breeding sites with drones and are introducing carp species and the larvae of giant mosquitoes, which eat mosquitoes that carry the chikungunya virus. As part of public awareness measues, red-and-yellow banners can be seen in Tengchong, bearing rhyming slogans that remind residents of the dangers of stagnant water and mosquitoes. Last week, provincial governor Wang Weizhong reportedly called on officials to encourage residents to light mosquito coils, install gauze netting and apply bug spray as part of a 'patriotic health campaign" to prevent the spread of the virus. Why Is It Being Compared To Covid-19? However, China's relentless campaign against mosquitoes has been compared to its extreme efforts to control the Covid-19 pandemic, notably by officials in Foshan instructing pharmacies to record the names of customers buying medicines for Chikungunya symptoms like rashes, joint pain and fevers. Two cities in the neighbouring Fujian province have issued reminders to visitors from Foshan to undergo 14 days of self-monitoring, FT reported citing state media. Medics in at least one affected area are registering the details of infected individuals with the local Communist party committee, which sends them to a special 'quarantine" hospital wards in which patients are separated by gauze netting, according to a health worker. Residents are tested via nucleic acid testing, sometimes conducted by health workers under temporary outdoor shelters that evoke memories of Covid-19 mass swabbing sites. A patient's stay in the quarantine hospital is dependent on these tests. However, some citizens have welcomed these steps. 'I hope the government can continue to implement all of these measures and keep exterminating mosquitoes frequently, so that we don't have to deal with the trouble that they bring," said Liu, a Tengchong resident who made a full recovery after contracting Chikungunya. view comments Location : Beijing, China First Published: August 10, 2025, 17:20 IST News world China's War On Mosquitoes To Eradicate Chikungunya Revives Covid Lockdown Memories: Report Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store